NovoCure Limited

NVCR

$14.16

Name : NovoCure Limited

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $1,583,077,888.00

EPSttm : -1.56

NovoCure Limited

$14.16

2.34%

$0.34

Float Short %

5.92

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

-0.13

EPS Last/This Y

-0.02

EPS This/Next Y

-0.13

Price

14.17

Target Price

26.94

Analyst Recom

1.75

Performance Q

-22.16

Relative Volume

0.73

Beta

0.79

Ticker: NVCR

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	NVCR	12.6	0.12	0.03	29181
2025-09-09	NVCR	12.65	0.12	0.06	29574
2025-09-10	NVCR	12.22	0.12	0.11	29943
2025-09-11	NVCR	12.73	0.12	0.05	29873
2025-09-12	NVCR	12.16	0.12	0.17	30203
2025-09-15	NVCR	12.71	0.12	0.13	30319
2025-09-16	NVCR	12.68	0.12	0.07	31202
2025-09-17	NVCR	12.69	0.11952774004806	0.16800920598389	32145
2025-09-18	NVCR	12.99	0.12	0.05	32596
2025-09-22	NVCR	13.09	0.12	0.58	29678
2025-09-23	NVCR	13	0.14	0.05	30473
2025-09-24	NVCR	12.85	0.14	0.02	30927
2025-09-25	NVCR	12.79	0.13	0.07	31672
2025-09-26	NVCR	12.89	0.13	0.04	32014
2025-09-29	NVCR	12.9	0.13	0.18	32068
2025-09-30	NVCR	12.92	0.13	0.53	32138
2025-10-01	NVCR	13.98	0.14	0.11	32151
2025-10-02	NVCR	14.06	0.13	0.16	32205
2025-10-03	NVCR	14.68	0.13	0.18	32440
2025-10-06	NVCR	14.5	0.14	0.29	33105
2025-10-07	NVCR	14.16	0.14	0.40	33236
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	NVCR	12.60	-51.0	-85.8	-1.58
2025-09-09	NVCR	12.66	-51.0	-80.9	-1.58
2025-09-10	NVCR	12.21	-51.0	-71.2	-1.58
2025-09-11	NVCR	12.73	-51.0	-89.9	-1.58
2025-09-12	NVCR	12.15	-51.0	-68.9	-1.58
2025-09-15	NVCR	12.73	-51.0	-91.1	-1.58
2025-09-16	NVCR	12.68	-51.0	-79.0	-1.58
2025-09-17	NVCR	12.69	-51.0	-79.9	-1.58
2025-09-18	NVCR	12.99	-51.0	-85.3	-1.58
2025-09-19	NVCR	12.69	-51.0	-74.1	-1.58
2025-09-22	NVCR	13.09	-51.0	-86.9	-1.58
2025-09-23	NVCR	13.01	-51.0	-78.2	-1.58
2025-09-24	NVCR	12.85	-51.0	-76.8	-1.58
2025-09-25	NVCR	12.78	-51.0	-78.5	-1.58
2025-09-26	NVCR	12.89	-51.0	-81.6	-1.58
2025-09-29	NVCR	12.90	-51.0	-79.9	-1.58
2025-09-30	NVCR	12.93	-51.0	-79.8	-1.58
2025-10-01	NVCR	13.97	-51.0	-98.6	-1.58
2025-10-02	NVCR	14.05	-51.0	-80.8	-1.58
2025-10-03	NVCR	14.68	-51.0	-90.0	-1.58
2025-10-06	NVCR	14.51	-51.0	-87.3	-1.58
2025-10-07	NVCR	14.17	-51.0	-74.4	-1.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	NVCR	0.49	-0.96	5.57
2025-09-09	NVCR	0.49	-0.96	5.57
2025-09-10	NVCR	0.49	-0.96	5.57
2025-09-11	NVCR	0.49	-0.96	6.03
2025-09-12	NVCR	0.49	-0.96	6.03
2025-09-15	NVCR	0.49	-0.91	6.01
2025-09-16	NVCR	0.50	-0.91	6.01
2025-09-17	NVCR	0.50	-0.91	6.01
2025-09-18	NVCR	0.50	-0.91	6.01
2025-09-19	NVCR	0.50	-0.91	6.01
2025-09-22	NVCR	0.50	-0.91	6.01
2025-09-23	NVCR	0.50	-0.91	6.01
2025-09-24	NVCR	0.50	-0.91	6.01
2025-09-25	NVCR	0.50	-0.91	5.93
2025-09-26	NVCR	0.50	-0.91	5.93
2025-09-29	NVCR	0.50	-0.90	5.92
2025-09-30	NVCR	0.51	-0.90	5.92
2025-10-01	NVCR	0.51	-0.90	5.92
2025-10-02	NVCR	0.51	-0.90	5.92
2025-10-03	NVCR	0.51	-0.90	5.92
2025-10-06	NVCR	0.51	-2.13	5.92
2025-10-07	NVCR	0.51	-2.13	5.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.42

Avg. EPS Est. Next Quarter

-0.49

Insider Transactions

0.51

Institutional Transactions

-2.13

Beta

0.79

Average Sales Estimate Current Quarter

158

Average Sales Estimate Next Quarter

160

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.9

Max Drawdown 5-Year %

-95.2

Target Price

26.94

P/E

Forward P/E

PEG

P/S

2.51

P/B

4.53

P/Free Cash Flow

EPS

-1.56

Average EPS Est. Cur. Y

-1.58

EPS Next Y. (Est.)

-1.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.13

Relative Volume

0.73

Return on Equity vs Sector %

-74.1

Return on Equity vs Industry %

-67.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-74.4

NovoCure Limited

Sector: Healthcare

Industry: Medical Devices

Employees: 1488

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

stock quote shares NVCR – NovoCure Limited Stock Price stock today

news today NVCR – NovoCure Limited stock forecast ,stock prediction 2023 2024 2025

marketwatch NVCR – NovoCure Limited yahoo finance google finance

stock history NVCR – NovoCure Limited invest stock market

stock prices NVCR premarket after hours

ticker NVCR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVCR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y